Search results
Author(s):
Gaetano Antonio Lanza
Added:
1 month ago
Author(s):
Shuo-wen Sun
,
Xing-jie Wang
,
Ruo-chen Yan
,
et al
Added:
2 months ago
Echo-stress in Myocardial Bridge
Author(s):
Priscilla Lamendola
,
Nello Cambise
,
Antonio Di Renzo
,
et al
Added:
1 year ago
Article
Author(s):
Valentina O Puntmann
,
Anastasia Shchendrygina
,
Carlos Rodriguez Bolanos
,
et al
Added:
1 year ago
Author(s):
Brian Lindman
Added:
3 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
Author(s):
Deesha Patel
,
Makrina D Savvidou
Added:
1 year ago
Author(s):
Priscilla Lamendola
,
Nello Cambise
,
Antonio Di Renzo
,
et al
Added:
11 months ago
Author(s):
Finn Gustafsson
Added:
1 year ago
HFA 24 - Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3 study (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were treated with two…
View more
Author(s):
Diana Hui Ping Foo
Added:
1 month ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,…
View more
Author(s):
Christophe Leclercq
Added:
3 months ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire…
View more